Metformin and erlotinib synergize to inhibit basal breast cancer.

Metformin and erlotinib synergize to inhibit basal breast cancer.

Item
http://www.wikidata.org/entity/Q34786488
Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer.On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancerEstrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Direct interaction of avermectin with epidermal growth factor receptor mediates the penetration resistance in Drosophila larvae.Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells.Metformin and cancer: Quo vadis et cui bono?Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models.Combinational strategies of metformin and chemotherapy in cancers.Obesity and Cancer Mechanisms: Cancer Metabolism.Biguanides and targeted anti-cancer treatments.Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control.Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt.Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators
P2860

Metformin and erlotinib synergize to inhibit basal breast cancer.

Item
http://www.wikidata.org/entity/Q34786488
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metformin and erlotinib synergize to inhibit basal breast cancer.
@ast
Metformin and erlotinib synergize to inhibit basal breast cancer.
@en
Metformin and erlotinib synergize to inhibit basal breast cancer.
@nl
type
label
Metformin and erlotinib synergize to inhibit basal breast cancer.
@ast
Metformin and erlotinib synergize to inhibit basal breast cancer.
@en
Metformin and erlotinib synergize to inhibit basal breast cancer.
@nl
prefLabel
Metformin and erlotinib synergize to inhibit basal breast cancer.
@ast
Metformin and erlotinib synergize to inhibit basal breast cancer.
@en
Metformin and erlotinib synergize to inhibit basal breast cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Metformin and erlotinib synergize to inhibit basal breast cancer.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932